Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Apolipoproteins are the protein constituents of lipoproteins, the particles that transport cholesterol and triglycerides in the plasma. Numerous epidemiologic studies have associated variations in plasma levels of lipoproteins and apolipoproteins with the development of atherosclerosis. Furthermore, genetic variations in lipoproteins and apolipoproteins have been associated with disorders of lipid metabolism. Recent advances in biochemical and molecular genetic methods have resulted in an increased understanding of interindividual variations in lipoprotein metabolism and of their relationship to atherosclerosis and the dyslipoproteinemias. In particular, certain DNA restriction fragment length polymorphisms of the apolipoprotein genes have, in the last few years, been associated with atherosclerotic diseases and dyslipoproteinemias. We believe that genetic markers, when used in conjunction with traditional clinical and biochemical determinations, may one day be useful in predicting atherosclerosis susceptibility in the general population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and is a genetically validated target to reduce ASCVD risk.8–10,64–66”
From Clinical review on triglycerides (2020) · cites this paper as [65]
Citations
Cites
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
The Metabolic Basis of Inherited Disease.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-3-425_3 · Cited by 2,687
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
A protein cofactor of lecithin:Cholesterol acyltransferase
Fielding, C. J., Shore, V. G., & Fielding, P. E. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90776-0 · Cited by 724
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
A specific apoprotein activator for lipoprotein lipase
LaRosa, J. C., Levy, R. I., Herbert, P., Lux, S. E., & Fredrickson, D. S. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90468-7 · Cited by 668
Sniderman, A., Shapiro, S., Marpole, D., Skinner, B., Teng, B., & Kwiterovich, P. O. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.1.604 · Cited by 633
Complete protein sequence and identification of structural domains of human apolipoprotein B
Knott, T. J., Pease, R. J., Powell, L. M., Wallis, S. C., Rall, S. C., Innerarity, T. L., Blackhart, B., Taylor, W. H., Marcel, Y., Milne, R., et al. (1986) · Nature · doi:10.1038/323734a0 · Cited by 620
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.
Kane, J. P., Hardman, D. A., & Paulus, H. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2465 · Cited by 584
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citation
Research works printed but not linked: 21
- Anderson RA, 1986, Apolipoprotein A‐I gene locus haplotypes and HDL‐cholesterol levels, Clin Res, 34, 889A
- Anderson RA, 1985, Apoprotein A‐I linked genetic polymorphisms associated with high density lipoprotein levels, Clin Res, 33, 15
- Antonarakis SE, 1986, DNA polymorphism of the human apolipoprotein AI‐CIII‐AIV gene cluster, Am J Hum Genet (Suppl)., 39, 549
- Assmann G, 1986, Lack of association between RFLPs of the human apolipoprotein CII gene locus and clinical manifestations of atherosclerosis, Am J Hum Genet (Suppl)., 39, 260
- Avogaro P, 1978, Plasma levels of apolipoprotein AI and apoprotein B in human atherosclerosis, Artery., 4, 385
- Chen CH, 1983, Enhancement of Apolipoprotein Ai‐Activated Human Plasma Lecithin: Cholesterol Acyl Transferase Activity by Apoprotein Aii, Arteriosclerosis., 3, 489a
- Cole SA, 1986, A population genetics study of apolipoprotein AI gene polymorphism, Am J Hum Genet (Suppl)., 39, 691
- DHHS, 1980, Lipid Research Clinics Population Studies Data Book. The Prevalence Study, 28
- Fojo SS, 1986, Analysis of apo C‐II patients with apo C‐II deficiency, Circulation, 74, 284
- FrossardP ColemanR FunkeH AssmannG(1985):Molecular genetics of the human apolipoprotein AI‐CIII gene complex: Application to detection of susceptibility to atherosclerosis. In “Proceedings of the 4th International Atherosclerosis Symposium.” Munster GDR.
- Frossard PM, 1986, Genetic markers for coronary atherosclerosis in the human apolipoprotein AI‐CIII‐AIV gene complex, Am J Hum Genet (Suppl)., 39, 589
- Havekes L, 1986, The apolipoprotein E polymorphism at the DNA level, Circulation, 74, 322
- Karathanasis SK, 1986, DNA inversion inactivates both the apo AI and apo CIII genes in patients with combined apo AI‐apo CIII deficiency and premature coronary artery disease, Circulation, 74, 157
- Karathanasis SK, 1984, Apo CIII gene defect in patients with combined apo A‐I‐CIII deficiency and premature atherosclerosis, Arteriosclerosis, 4, 562a
- Kostner GM, 1986, The interactional of lipoproteina with glycosaminoglycans: Possible mechanism for its atherogenicity, Circulation, 74, 25
- Lim D, 1986, Deletion of an Alu sequence in the 5′ of the apolipoprotein AI gene associated with decreased serum HDL‐cholesterol levels, Am J Hum Genet (Suppl)., 39, 621
- Menzel HJ, 1984, Human apolipoprotein A‐I gene polymorphism, J Biol Chem, 259, 3070
- Schaefer EJ, 1986, Apolipoprotein E isoforms in the Framingham Offspring Study: Significance of variant alleles, Circulation, 74, 202
- Schulte H, 1986, The MspI RFLP 3′ to the human apolipoprotein AII gene is neutral with respect to atherosclerosis in Germans, Am J Hum Genet (Suppl)., 39, 293
- Scott J, 1985, High density lipoprotein composition is altered by a common DNA polymorphism adjacent to apolipoprotein A‐II gene in man, Lancet, 1, 770
- Weisgraber KH, 1986, Apolipoprotein B heparin binding sites: Insights into the receptor binding domain, Circulation, 74, 106
Cited by
Clinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
Self-citationBoerwinkle, E., Xiong, W. J., Fourest, E., & Chan, L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.212 · Cited by 467
Genetics of hypertriglyceridemia
Dron, J. S., & Hegele, R. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00455 · Cited by 244
Self-citationGenetic factors affecting blood lipoproteins: the candidate gene approach.
Lusis, A. J. (1988) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38516-3 · Cited by 221
Leung, S. Y., Ng, T. H., Yuen, S. T., Lauder, I. J., & Ho, F. C. (1993) · Stroke · doi:10.1161/01.str.24.6.779 · Cited by 205
Metadata
- Authors
- Hegele, R. A., Breslow, J. L., & Cloninger, C. R.
- Affiliations
- Rockefeller University (US)
- Corresponding author
- Breslow, Jan L.
- Venue
- Genetic Epidemiology
- Publisher
- Wiley
- Published
- 1987-01
- Volume
- 4
- Issue
- 3
- Pages
- 163-184
- ISSN
- 0741-0395 (ISSN-L)
- 1098-2272
- OpenAlex
- W1729623267
- Cited by
- 60
- References
- 79
- Citations by year
- 2023: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2017: 1 · 2013: 2 · 2012: 1
- FWCI
- 12.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Genetic Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- apolipoproteins, atherosclerosis susceptibility, genetic variation, restriction fragment length polymorphism, apolipoprotein genes, dyslipoproteinemia, lipid metabolism disorders, genetic markers, lipoprotein metabolism, cardiovascular risk prediction
- MeSH terms
- Apolipoproteins, Arteriosclerosis, Chromosome Mapping, Disease Susceptibility, Genes, Humans, Polymorphism, Restriction Fragment Length, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility. https://app.cochat.ai/papers/10.1002/gepi.1370040302
- The paper
- Hegele, R. A., Breslow, J. L., & Cloninger, C. R. (1987). Apolipoprotein genetic variation in the assessment of atherosclerosis susceptibility. Genetic Epidemiology. https://doi.org/10.1002/gepi.1370040302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.